ARCHIVES

HHS Carcinogen Guidelines For Labs Could Apply To Other

This article is from The Cancer Letter archive.

Vol. 06 No. 22 | May 30, 1980

Download PDF Visit The Full Archive

Related Articles

Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says

September 26, 2014

More Minorities, Women, Fewer MD On Study Sections

September 2, 1988

Final Issues Of 1982

December 10, 1982

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

March 1, 2002

NCI Advisors Approve $100M Set Aside for Physical Sciences-Oncology Centers.

December 12, 2008

NCCR Seeks #380 Mil. Increase For NIC In FY 1994; Calls ‘First Step’ In Reaching Byspass Budget Level

February 26, 1993